Protection conferred by commercial infectious bronchitis (IB) vaccines against

Abstract

The level o protection conferred by commercial vaccines against the new variant Nebraska 95 isolate was evaluated. Complete protection was observed when the IBV Arkansas vaccine was given and when the Massachusetts-Connecticut vaccine was given at 1 and at 1 and 10 days of age. However, partial protection was observed when the Massachusetts-Connecticut… (More)

Topics

10 Figures and Tables

Cite this paper

@inproceedings{Alvarado2002ProtectionCB, title={Protection conferred by commercial infectious bronchitis (IB) vaccines against}, author={Ivan Ricardo Alvarado and Pedro Julio Villegas and Ricardo E Alvarado and Mark W. Jackwood and Charles C Hofacre and Gordhan L. Patel}, year={2002} }